Ipsen SA (IPSEF) reports robust financial performance with a 9.9% sales increase and strategic pipeline developments, despite ...
UBS analyst Xian Deng maintained a Buy rating on Ipsen (0MH6 – Research Report) today and set a price target of €145.00. The company’s shares ...
In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on ...